Examkin

Tüm alıştırma soruları

4736 soru

Tüm türler4,736Çoktan seçmeli2,413Çoklu seçim567Sayısal127Eşleştirme858Sıralama771
Soru 141Soru →

A physician is preparing to discuss recent imaging findings with a 59-year-old man and his spouse. The patient underwent a computed tomography scan of the chest due to chronic cough and weight loss, which revealed a large spiculated pulmonary mass with mediastinal lymphadenopathy, highly suspicious for advanced malignancy. The physician plans to deliver this information using the SPIKES protocol. Arrange the following physician statements in the correct chronological sequence to appropriately execute this framework.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence for the SPIKES protocol is: 1) Assessing the patient's understanding, 2) Asking for permission regarding detail level, 3) Disclosing the diagnosis, 4) Responding to emotional distress empathetically, and 5) Formulating a follow-up plan.
The SPIKES protocol is a standard, structured approach for delivering bad news. It consists of six steps: Setting up the interview (implied in the stem), assessing the patient's Perception, obtaining the patient's Invitation, giving Knowledge, addressing Emotions with empathic responses, and establishing a Strategy/Summary. The correct chronological sequence requires the physician to first gauge what the patient already suspects (Perception), then ask how much detail they desire (Invitation). Only then should the physician deliver the diagnosis, preceded by a warning phrase (Knowledge). Following the disclosure, the physician must prioritize responding to the patient's affective state with validation and empathy (Emotion) before finally establishing a concrete medical plan for the future (Strategy).

Adım Adım Çözüm

1
Identify the communication framework required for this clinical scenario.
The scenario involves disclosing a highly suspicious malignancy, which requires the SPIKES protocol for delivering bad news.
Structured frameworks like SPIKES reduce patient anxiety and improve physician confidence during difficult conversations.
2
Identify the first required action among the provided statements.
The statement assessing the patient's current understanding ('Before we discuss the CT scan results...') is selected.
This aligns with 'Perception' (P), allowing the physician to correct misinformation and tailor the subsequent dialogue.
3
Select the statement that establishes the patient's information preferences.
The statement asking how much detail is desired ('Would you like me to go over all the specific details...') is chosen.
This aligns with 'Invitation' (I), ensuring the physician respects the patient's right to know or not know specific details.
4
Identify the statement that formally delivers the diagnosis.
The statement providing the scan findings with a warning phrase ('I am afraid the scan results are concerning...') is selected.
This aligns with 'Knowledge' (K), delivering the medical truth clearly and without confusing jargon.
5
Select the most appropriate immediate response to the delivered bad news.
The statement offering empathy ('I can see that this is a tremendous shock...') is chosen.
This aligns with 'Emotions' (E), validating the patient's psychological distress before moving on to clinical logistics.
6
Identify the concluding statement that outlines the next steps.
The statement regarding scheduling a biopsy ('When you are ready, we can talk about scheduling...') is selected.
This aligns with 'Strategy and Summary' (S), establishing a concrete follow-up plan so the patient does not feel abandoned.

Anahtar Kavram

Applying the SPIKES communication protocol for delivering bad news
Tahmini Süre:2m 0s
Soru 142Soru →

A 68-year-old man is admitted to the medical ward with decompensated cirrhosis, a recent gastrointestinal bleed, and acute hepatic encephalopathy. During his first night in the hospital, he becomes highly agitated, pulls out his intravenous lines, and insists he is leaving immediately to "catch a flight for a business trip," despite having been retired for over a decade. He is profoundly disoriented to place and time. If he leaves the hospital, he is at extremely high risk for life-threatening complications. Arrange the following physician actions in the most appropriate chronological sequence for managing this acute situation.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is to first assess and document the lack of capacity, then detain the patient to prevent harm, provide emergent treatment, contact the surrogate for ongoing care, and finally reassess capacity once the patient's clinical status improves.
In acute situations where a patient with altered mental status attempts to leave against medical advice, the physician must follow a stepwise ethical approach. First, capacity must be rapidly assessed and documented. If the patient lacks capacity, the physician must act in their best interest to prevent imminent harm by detaining them using the least restrictive means. The doctrine of implied consent then allows for the immediate treatment of the underlying reversible cause (e.g., hepatic encephalopathy). Once the immediate danger is mitigated, the surrogate decision-maker should be contacted to obtain consent for ongoing, non-emergent interventions. Finally, because decision-making capacity is dynamic, it must be regularly reassessed as the patient's clinical condition improves to restore their autonomy.

Adım Adım Çözüm

1
Assess decision-making capacity
Confirmation that the patient cannot appreciate the risks of leaving.
Establishes the ethical and legal justification for overriding the patient's autonomy.
2
Detain the patient
The patient is prevented from leaving the hospital.
Protects the incapacitated patient from imminent, life-threatening harm.
3
Administer emergent treatment
Initiation of therapies to reverse hepatic encephalopathy.
Standard of care for a life-threatening illness, provided under the doctrine of implied consent.
4
Contact the surrogate decision-maker
Establishment of a collaborative ongoing care plan.
Required for informed consent for non-emergent treatments while the patient remains incapacitated.
5
Reassess capacity
Determination of whether the patient can resume independent decision-making.
Capacity is state-dependent; restoration of autonomy should occur as soon as the underlying condition resolves.

Anahtar Kavram

Management of acute incapacity and refusal of care in life-threatening emergencies.
Soru 143Soru →

A first-year internal medicine resident is covering the intensive care unit overnight. A 68-year-old patient receiving continuous norepinephrine therapy via a peripheral intravenous line develops severe blanching, coldness, and swelling at the infusion site. The resident contacts the covering critical care fellow, who instructs the resident to 'leave it alone and just observe for now,' citing that placing a new central line would disrupt their workflow. The resident firmly believes the peripheral line must be stopped immediately to prevent severe tissue necrosis.

According to standard interprofessional patient safety and conflict resolution protocols, arrange the following actions in the correct sequential order for escalating and managing this safety concern.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence follows standard escalation protocols: First, express the clinical observation to the fellow. Second, reassert the concern using standardized safety language. Third, escalate to the attending physician via the chain of command. Finally, after securing the patient, file a formal safety event report.
The correct sequence mirrors the TeamSTEPPS Two-Challenge Rule and standard escalation policies. A provider must first voice the clinical concern (Challenge 1). If ignored, they must voice it again using standardized safety language like 'uncomfortable' or 'safety issue' (Challenge 2). If the conflict persists and patient safety remains at risk, they must 'stop the line' and escalate via the chain of command to the attending physician. Incident reporting is an essential final step, but it is strictly retrospective and must only occur after the patient is safe.

Adım Adım Çözüm

1
Initiate the first challenge by presenting the clinical findings and recommendation to the fellow.
The fellow receives the initial voice of concern regarding the extravasation risk.
Standard protocols require addressing the primary decision-maker directly before utilizing stronger language or escalating.
2
Apply the Two-Challenge Rule using standardized terminology (e.g., CUS).
The fellow is given a second, unambiguous warning regarding patient safety.
If the initial concern is dismissed, a stronger, structured assertion is required to overcome hierarchical barriers.
3
Escalate the situation via the chain of command by contacting the attending physician.
The attending physician is notified to intervene and make a final clinical decision.
When the Two-Challenge Rule fails to resolve an imminent threat, chain of command activation is mandatory to protect the patient.
4
Complete administrative incident reporting.
The event is logged in the hospital's safety system for review.
System-level reporting is vital for quality improvement but must strictly occur only after the patient is clinically secured.

Anahtar Kavram

The Two-Challenge Rule and sequential chain-of-command escalation in patient safety.
Soru 144Soru →

A male patient, aged 6262 years, returns to the primary care clinic for a follow-up evaluation. He has a history of type 22 diabetes mellitus, essential hypertension, and hyperlipidemia. Two weeks ago, his blood pressure was 154/92154/92 mmHg. At that time, laboratory studies demonstrated a serum creatinine of 1.11.1 mg/dL, a serum potassium of 4.24.2 mEq/L, and a urine albumin-to-creatinine ratio of 210210 mg/g. To address his hypertension and microalbuminuria, ramipril was initiated. Today, the patient reports feeling well with no lightheadedness, shortness of breath, or peripheral edema. His blood pressure is now 132/82132/82 mmHg, and his heart rate is 7474/min. Repeat laboratory studies obtained this morning show a serum sodium of 139139 mEq/L, a serum potassium of 4.84.8 mEq/L, a blood urea nitrogen of 1616 mg/dL, and a serum creatinine of 1.41.4 mg/dL. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Continue ramipril at the current dose

Cevap

Continue ramipril at the current dose
The correct answer is to continue the medication at the current dose. Angiotensin-converting enzyme (ACE) inhibitors, such as ramipril, inhibit the conversion of angiotensin I to angiotensin II. Angiotensin II normally constricts the efferent arteriole of the glomerulus. By blocking this effect, ACE inhibitors cause efferent arteriolar vasodilation, which lowers intraglomerular pressure. This is a highly desirable effect in diabetic nephropathy because it reduces protein spillage (albuminuria) and slows the progression of chronic kidney disease. However, lowering the intraglomerular pressure also mildly decreases the glomerular filtration rate (GFR), which manifests as a slight rise in serum creatinine. Guidelines establish that an initial rise in serum creatinine of up to 30% from baseline within the first few weeks of therapy is a normal and acceptable physiological response. In this patient, the creatinine increased from 1.1 mg/dL to 1.4 mg/dL (a 27% increase). Because the increase is less than 30%, his serum potassium is acceptable (<5.0 mEq/L), and his blood pressure is well controlled, the most appropriate action is to continue the current regimen and monitor.

Adım Adım Çözüm

1
Evaluate the patient's current blood pressure compared to the previous visit.
Blood pressure has improved from 154/92 mmHg to 132/82 mmHg.
To determine the clinical efficacy of the newly initiated antihypertensive therapy.
2
Calculate the percentage increase in serum creatinine from baseline.
Creatinine increased from 1.1 mg/dL to 1.4 mg/dL, an absolute increase of 0.3 mg/dL, which is approximately a 27% increase.
To differentiate between an expected physiological hemodynamic change and pathological acute kidney injury.
3
Assess the serum potassium level for hyperkalemia.
Potassium is 4.8 mEq/L, which is within the normal range.
ACE inhibitors can decrease aldosterone secretion, leading to potentially dangerous potassium retention.
4
Determine the appropriate management plan based on the lab findings.
Because the creatinine bump is less than 30%, potassium is normal, and blood pressure is controlled, the therapy should be maintained.
To maximize the renoprotective benefits of the ACE inhibitor for diabetic nephropathy without compromising patient safety.

Anahtar Kavram

Patients initiated on ACE inhibitors or ARBs may experience a physiological increase in serum creatinine of up to 30% above baseline; if the increase is within this limit and hyperkalemia is absent, the medication should be continued.
Soru 145Soru →

A 68-year-old male with a history of type 2 diabetes mellitus is admitted to the intensive care unit due to severe community-acquired pneumonia and worsening hypotension. His weight is 80 kg. Upon arrival, his blood pressure is 75/40 mm Hg, heart rate is 128/min, and respiratory rate is 28/min. Initial laboratory results demonstrate a serum lactate of 5.2 mmol/L. Appropriate empiric broad-spectrum antibiotics have already been administered. Arrange the following pharmacologic interventions in the correct sequential order of escalation for managing this patient's hemodynamics, assuming he remains persistently hypotensive after each preceding step is fully implemented.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is to first administer a 30 mL/kg fluid bolus (2.4 L balanced crystalloid), followed by starting a norepinephrine infusion if hypotension persists. If the mean arterial pressure remains inadequate, a vasopressin infusion should be added next. Finally, if the patient is in refractory shock despite fluids and vasopressors, intravenous hydrocortisone is indicated.
The Surviving Sepsis Campaign guidelines emphasize a strict stepwise approach to hemodynamic resuscitation. Initial stabilization requires rapidly restoring intravascular volume with a 30 mL/kg bolus of crystalloids. If the mean arterial pressure (MAP) remains below 65 mm Hg after fluids, the first-line vasopressor, norepinephrine, must be initiated. Vasopressin is subsequently added to augment vascular tone and reduce the required dose of norepinephrine. Intravenous corticosteroids (hydrocortisone) are reserved as a final pharmacologic step for refractory shock that does not respond to adequate fluids and multiple vasopressor therapies.

Adım Adım Çözüm

1
Administer 30 mL/kg of intravenous crystalloids (2.4 L).
Initial restoration of intravascular volume.
Sepsis causes profound vasodilation and capillary leak; guidelines mandate an initial fluid bolus within the first 3 hours to correct absolute and relative hypovolemia.
2
Initiate intravenous norepinephrine.
Vasoconstriction and increase in mean arterial pressure.
If the mean arterial pressure remains below 65 mm Hg despite adequate fluid resuscitation, norepinephrine is the primary first-line vasopressor to restore vascular tone.
3
Add intravenous vasopressin.
Synergistic vasoconstriction and catecholamine sparing.
Vasopressin is added when norepinephrine doses are escalating or inadequate, acting via V1 receptors to increase blood pressure without further adrenergic stimulation.
4
Administer intravenous hydrocortisone.
Reversal of relative adrenal insufficiency.
Corticosteroids are indicated exclusively for refractory septic shock that does not respond to adequate fluid resuscitation and moderate-to-high doses of multiple vasopressors.

Anahtar Kavram

The stepwise hemodynamic escalation protocol for septic shock: Crystalloids -> Norepinephrine -> Vasopressin -> Corticosteroids.
Soru 146Soru →

A 65-year-old man presents to the clinic with severe pain, swelling, and redness in his right knee that began 24 hours ago. He has a history of ischemic cardiomyopathy with a left ventricular ejection fraction of 30%, chronic kidney disease stage 4 with a baseline estimated glomerular filtration rate of 22 mL/min/1.73 m², and a prior episode of upper gastrointestinal bleeding secondary to a peptic ulcer. Vital signs show a temperature of 37.4°C (99.3°F), blood pressure of 110/70 mmHg, and heart rate of 82/min. Physical examination reveals a warm, erythematous, and markedly tender right knee with a moderate effusion. Arthrocentesis is performed, and synovial fluid analysis reveals a leukocyte count of 28,000/mm³ and the presence of negatively birefringent, needle-shaped crystals under polarizing microscopy. Gram stain reveals no organisms. Which of the following is the most appropriate initial pharmacologic intervention for this patient's acute symptoms?

Cevabı ve açıklamayı göster

Cevap: Intra-articular triamcinolone

Cevap

The correct answer is intra-articular triamcinolone.
The patient is experiencing an acute gout flare, evidenced by sudden-onset monoarticular pain, swelling, and synovial fluid containing negatively birefringent, needle-shaped crystals. Standard first-line treatments for acute gout include nonsteroidal anti-inflammatory drugs (NSAIDs), colchicine, and systemic or intra-articular glucocorticoids. When selecting a therapy, the patient's comorbidities must be heavily considered. This patient has advanced chronic kidney disease (eGFR 22 mL/min/1.73 m²), heart failure with reduced ejection fraction, and a history of peptic ulcer disease. NSAIDs are absolutely contraindicated due to the high risk of exacerbating his renal failure, promoting fluid retention that could decompensate his heart failure, and causing recurrent gastrointestinal bleeding. Colchicine is cleared by the kidneys and requires extreme caution or strict avoidance in severe renal impairment due to the risk of life-threatening bone marrow suppression and neuromyopathy. While systemic glucocorticoids could be used, they carry a risk of fluid retention. Because the patient has monoarticular involvement, an intra-articular glucocorticoid injection (such as triamcinolone) provides targeted, highly effective anti-inflammatory action with minimal systemic absorption, making it the safest initial pharmacologic intervention.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation and synovial fluid results.
The presence of negatively birefringent, needle-shaped crystals and a sterile inflammatory synovial fluid confirms an acute gout flare.
Establishing the correct diagnosis is prerequisite to selecting the appropriate targeted pharmacologic therapy.
2
Evaluate the patient's medical history for contraindications to standard gout therapies.
The patient has advanced chronic kidney disease (CKD stage 4), heart failure with reduced ejection fraction, and a history of peptic ulcer disease.
First-line systemic therapies for gout (NSAIDs, colchicine) have significant toxicities that must be weighed against patient comorbidities.
3
Select the safest and most effective targeted intervention for monoarticular gout.
Intra-articular triamcinolone is chosen over systemic agents.
NSAIDs and colchicine are contraindicated or highly risky due to his medical history. A local intra-articular corticosteroid injection provides excellent relief with minimal systemic side effects.

Anahtar Kavram

Selecting the appropriate acute treatment for gout flares by identifying absolute and relative contraindications to NSAIDs and colchicine based on patient comorbidities.
Soru 147Soru →

A 32-year-old woman with relapsing-remitting multiple sclerosis presents to the clinic to discuss changing her disease-modifying therapy. She has experienced two clinical relapses in the past year while receiving glatiramer acetate. The physician plans to prescribe fingolimod. The patient has no other significant past medical history. She was born outside the United States, has no records of her childhood immunizations, and does not recall having chickenpox. Her physical examination is notable for mild residual weakness in her left lower extremity.

Which of the following baseline evaluations are required prior to initiating this medication? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Electrocardiogram; Varicella-zoster virus IgG antibody testing; Ophthalmic evaluation

Cevap

The necessary baseline evaluations prior to initiating fingolimod are an electrocardiogram, varicella-zoster virus IgG antibody testing, and an ophthalmic evaluation.
Fingolimod is an oral sphingosine-1-phosphate receptor modulator. Its initiation requires specific baseline monitoring to mitigate severe, predictable adverse effects. First, an electrocardiogram is required because the drug can cause significant first-dose bradycardia and atrioventricular block. Second, varicella-zoster virus IgG antibody testing is necessary in patients without a confirmed history of chickenpox or vaccination; those who test negative must receive the varicella vaccine before starting therapy due to the risk of severe, disseminated VZV infections. Third, an ophthalmic evaluation is required at baseline and 3 to 4 months after initiation because of the well-documented risk of fingolimod-associated macular edema.

Adım Adım Çözüm

1
Identify the planned pharmacotherapy and its unique adverse effect profile.
The physician plans to prescribe fingolimod, an oral sphingosine-1-phosphate (S1P) receptor modulator used for multiple sclerosis.
Different disease-modifying therapies for multiple sclerosis have distinct mechanisms of action that necessitate highly specific baseline screening protocols.
2
Determine the cardiovascular risks associated with the medication.
Fingolimod binds to S1P receptors in the cardiac conduction system, which can cause a transient but significant decrease in heart rate and potential atrioventricular (AV) block.
To establish a baseline and identify any pre-existing conduction abnormalities, an electrocardiogram is strictly required before administering the first dose.
3
Determine the infectious disease risks and immunization requirements.
Because the patient lacks confirmed immunity to varicella (no records, no history of chickenpox), varicella-zoster virus (VZV) IgG antibody testing is necessary.
Fingolimod sequesters lymphocytes in lymph nodes, increasing the risk of severe, disseminated VZV infections. Non-immune patients must be vaccinated and wait one month prior to starting therapy.
4
Determine the ocular risks associated with the medication.
Fingolimod increases the risk of macular edema.
A baseline ophthalmic evaluation (often including macular optical coherence tomography) is required to ensure no pre-existing macular pathology, followed by a repeat evaluation 3 to 4 months after initiation.

Anahtar Kavram

Fingolimod initiation requires a baseline electrocardiogram (due to first-dose bradycardia/AV block risk), varicella-zoster virus serology in patients without confirmed immunity (due to severe disseminated infection risk), and an ophthalmic evaluation (due to macular edema risk).
Soru 148Soru →

Determine the optimal post-discharge transition for the following individuals who no longer require acute inpatient hospitalization. Select the corresponding facility or service that best aligns with each individual's functional capacity and ongoing medical requirements.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 54-year-old who survived acute respiratory distress syndrome, remains ventilator-dependent via tracheostomy, and needs specialized, prolonged weaning protocols.
A 68-year-old who is medically optimized after an ischemic stroke and demonstrates the stamina to participate in at least three hours of combined daily therapies.
An 82-year-old recovering from hip fracture repair who cannot bear weight, fatigues after 40 minutes of physical therapy, and requires assistance with bathing and dressing.
A 75-year-old with a recent heart failure exacerbation who is transitioning to oral diuretics and requires intermittent skilled nursing for disease education and weight monitoring at their residence.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The patients must be matched based on their medical complexity and therapy tolerance: the ventilator-dependent patient requires an LTACH, the stroke patient with high stamina goes to an IRF, the easily fatigued hip fracture patient to a SNF, and the stable heart failure patient qualifies for Home Health Services.
Each match correctly aligns with Medicare guidelines for post-acute care transitions. LTACHs are for medically complex patients requiring long-term interventions like ventilator weaning. IRFs are strictly for patients capable of engaging in intensive, 3-hour daily therapy. SNFs serve those needing subacute rehabilitation who cannot tolerate IRF-level intensity. Home Health is for homebound individuals needing intermittent skilled visits.

Adım Adım Çözüm

1
Assess the medical stability and specific interventions required for the 54-year-old patient.
The patient requires prolonged ventilator weaning.
This is a highly specialized medical need that mandates transfer to a Long-Term Acute Care Hospital (LTACH).
2
Evaluate the functional capacity and therapy stamina of the 68-year-old stroke patient.
The patient can participate in at least three hours of therapy per day.
Meeting the 'three-hour rule' qualifies the patient for admission to an Inpatient Rehabilitation Facility (IRF).
3
Determine the physical therapy tolerance and daily assistance needs of the 82-year-old patient.
The patient fatigues after 40 minutes of therapy but still requires significant assistance and skilled care.
Because the patient cannot tolerate intensive therapy, a Skilled Nursing Facility (SNF) is the appropriate setting.
4
Analyze the post-discharge needs of the 75-year-old heart failure patient.
The patient is stable but needs intermittent monitoring and education.
The patient does not require a 24-hour facility and can be safely managed with Home Health Services.

Anahtar Kavram

Appropriate selection of post-acute care settings relies on assessing the patient's ongoing medical complexity (e.g., ventilator dependence for LTACH), need for daily physician oversight, and their ability to tolerate varying intensities of rehabilitation (e.g., the 3-hour rule for IRFs versus SNFs).
Soru 149Soru →

A 68-year-old man is being prepared for discharge after a 6-day hospitalization for a severe exacerbation of chronic obstructive pulmonary disease (COPD). His acute symptoms have resolved, but he exhibits persistent hypoxemia. The multidisciplinary care team determines he will require new long-term home oxygen therapy (LTOT). Arrange the following steps in the most appropriate chronological order to safely execute this care setting transition.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence begins with documenting physiologic qualification, followed by ordering the equipment, confirming its placement at the residence, providing safety education, and finally discharging the patient with transport oxygen.
A safe care transition requires a logical progression: proving the medical need, prescribing the intervention, securing the environment (equipment delivery), ensuring patient competence (education), and safely bridging the physical transfer. Any disruption to this order threatens patient safety and increases readmission risk.

Adım Adım Çözüm

1
Document clinical eligibility for home oxygen.
Pulse oximetry confirms SpO2≤88%SpO_2 \leq 88\%.
Regulatory and clinical standards require objective proof of hypoxemia before prescribing LTOT.
2
Prescribe therapy and coordinate with the supplier.
CMN and prescription are sent to the DME company.
The supplier needs legal medical documentation to process and deliver the oxygen equipment.
3
Verify equipment setup at the destination.
Confirmation is received that the home concentrator is ready.
Discharging the patient before the home equipment is established risks profound hypoxemia upon arrival.
4
Administer targeted patient education.
The patient understands fire risks and oxygen titration.
Patients must be educated on the severe burn risks of oxygen therapy immediately prior to assuming independent use.
5
Execute the physical discharge.
The patient leaves the hospital safely.
Transit requires a portable oxygen source to bridge the gap between hospital wall oxygen and the home concentrator.

Anahtar Kavram

Safe discharge transition and coordination for new long-term oxygen therapy (LTOT)
Soru 150Soru →

A 72-year-old man is admitted to the inpatient medical ward for severe, poorly controlled lower back and pelvic pain secondary to metastatic prostate cancer. He reports that the pain has progressively worsened over the past two weeks and is now 9/10 in intensity. His current pain regimen consists of oral acetaminophen and oral ibuprofen, which currently provide minimal relief. His medical history is significant for hypertension, major depressive disorder, and chronic kidney disease stage 4 (baseline estimated glomerular filtration rate is 22 mL/min/1.73 m²). Current daily medications include amlodipine, sertraline, acetaminophen, and ibuprofen. Vital signs are temperature 37.1°C (98.8°F), blood pressure 152/88 mm Hg, pulse 98/min, and respirations 18/min. Physical examination reveals exquisite tenderness to palpation over the lumbar spine and posterior pelvis. The patient is awake, alert, and expresses a strong desire for immediate pain relief. The attending physician plans to discontinue the ibuprofen and initiate a strong opioid. Which of the following is the most appropriate pharmacologic intervention for this patient's pain?

Cevabı ve açıklamayı göster

Cevap: Intravenous fentanyl via patient-controlled analgesia

Cevap

Intravenous fentanyl via patient-controlled analgesia
Intravenous fentanyl via patient-controlled analgesia is the safest and most effective choice for this patient. Fentanyl undergoes hepatic metabolism into inactive metabolites, making it an ideal opioid for patients with advanced chronic kidney disease (CKD) or end-stage renal disease, as there is no risk of toxic metabolite accumulation. Furthermore, because the patient is in a state of acute, severe pain crisis, the intravenous route allows for rapid dose titration and immediate analgesic effect.

Adım Adım Çözüm

1
Identify the primary clinical objective and acuity.
The patient requires immediate relief for severe (9/10), acute-on-chronic cancer pain.
This establishes the need for a rapid-acting, potent analgesic route (e.g., intravenous rather than transdermal).
2
Analyze the patient's comorbidities that restrict pharmacologic choices.
The patient has stage 4 chronic kidney disease (eGFR 22 mL/min/1.73 m²).
Renal impairment dictates which opioids and analgesics are safe, as some produce toxic metabolites that rely on renal clearance.
3
Review the patient's current medication list for potential drug-drug interactions.
The patient is taking sertraline, a selective serotonin reuptake inhibitor (SSRI).
Adding medications with serotonergic activity (like tramadol or meperidine) increases the risk of serotonin syndrome.
4
Select the most appropriate analgesic and route based on the established constraints.
Intravenous fentanyl is selected.
Fentanyl lacks active metabolites (making it safe in CKD), does not interact with SSRIs, and the IV PCA route provides the rapid onset necessary for acute pain stabilization.

Anahtar Kavram

In patients with advanced chronic kidney disease, opioids that lack active, renally cleared metabolites (such as fentanyl and methadone) are preferred. Morphine should be avoided due to the accumulation of neurotoxic metabolites.
Soru 151Soru →

A 4545-year-old man comes to the clinic for a routine follow-up. Four weeks ago, he was diagnosed with active pulmonary tuberculosis and started on a regimen of isoniazid, rifampin, pyrazinamide, and ethambutol. He reports excellent adherence to the medications and says his chronic cough and night sweats have completely resolved. He currently feels well and has no nausea, vomiting, abdominal pain, fatigue, or dark urine. Vital signs are within normal limits. Physical examination reveals no scleral icterus, right upper quadrant tenderness, or hepatomegaly.

Laboratory studies show:

TestResultReference Range
Total bilirubin0.90.9 mg/dL0.10.1-1.21.2 mg/dL
Aspartate aminotransferase (AST)145145 U/L1010-4040 U/L
Alanine aminotransferase (ALT)152152 U/L77-5656 U/L
Alkaline phosphatase9090 U/L4444-147147 U/L

Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Continue the current medication regimen and repeat liver function tests in 1 to 2 weeks

Cevap

Continue the current medication regimen and repeat liver function tests in 1 to 2 weeks
The correct answer is to continue the current medication regimen and repeat liver function tests in 1 to 2 weeks. Mild, asymptomatic elevation of hepatic transaminases is a well-known side effect of first-line antituberculous therapy, particularly with isoniazid, rifampin, and pyrazinamide. Clinical guidelines dictate that these hepatotoxic medications should be continued with close monitoring unless hepatic transaminases rise to greater than 5 times the upper limit of normal in an asymptomatic patient, or greater than 3 times the upper limit of normal in a symptomatic patient (e.g., presenting with nausea, vomiting, jaundice, or significant abdominal pain). In this scenario, the patient is completely asymptomatic and the AST (145145 U/L) and ALT (152152 U/L) are both well below the 5-fold threshold. Therefore, stopping or altering the therapy is not indicated, and the patient should simply undergo repeat laboratory monitoring.

Adım Adım Çözüm

1
Evaluate the patient's clinical presentation and laboratory results.
The patient is asymptomatic (no nausea, vomiting, or jaundice) but has elevated AST (145145 U/L, < 4x ULN) and ALT (152152 U/L, < 3x ULN).
Determining the presence of symptoms and the exact degree of liver enzyme elevation is required to guide management of drug-induced liver injury.
2
Apply guidelines for managing hepatotoxicity during tuberculosis treatment.
Hepatotoxic drugs (isoniazid, rifampin, pyrazinamide) should only be stopped if transaminases are > 3 times the upper limit of normal in a symptomatic patient, or > 5 times the upper limit of normal in an asymptomatic patient.
Continuing therapy prevents treatment failure while safely monitoring for severe toxicity.
3
Select the appropriate next clinical step.
Since the transaminases are below the 5-fold threshold and the patient is completely asymptomatic, the medications should be continued and liver function tests monitored closely.
This approach aligns with standard of care for monitoring adverse effects of antituberculous therapy.

Anahtar Kavram

Asymptomatic patients taking first-line antituberculous therapy with hepatic transaminase levels less than 5 times the upper limit of normal should continue their current regimen with close clinical and laboratory monitoring.
Soru 152Soru →

Emergency medical services bring a 7272-year-old woman to the emergency department after her daughter found her profoundly weak and confused at home. According to the daughter, the patient has had severe nausea, vomiting, and non-bloody diarrhea for the past 33 days.

The patient's medical history includes type 2 diabetes mellitus, hypertension, and osteoarthritis. Her home medications include metformin, empagliflozin, lisinopril, and naproxen as needed.

Vital signs are:
ParameterValue
Temperature37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F})
Heart rate118/min118/\text{min}
Blood pressure86/54 mmHg86/54\text{ mmHg}
Respiratory rate18/min18/\text{min}
Oxygen saturation96%96\% on room air

Physical examination reveals dry oral mucous membranes, poor skin turgor, and delayed capillary refill. She is lethargic but arousable and oriented to person.

Laboratory results are as follows:
TestResultReference Range
Sodium132 mEq/L132\text{ mEq/L}136136-145 mEq/L145\text{ mEq/L}
Potassium5.2 mEq/L5.2\text{ mEq/L}3.53.5-5.0 mEq/L5.0\text{ mEq/L}
Chloride98 mEq/L98\text{ mEq/L}9595-105 mEq/L105\text{ mEq/L}
Bicarbonate18 mEq/L18\text{ mEq/L}2222-28 mEq/L28\text{ mEq/L}
Blood urea nitrogen62 mg/dL62\text{ mg/dL}77-18 mg/dL18\text{ mg/dL}
Creatinine2.6 mg/dL2.6\text{ mg/dL}0.60.6-1.2 mg/dL1.2\text{ mg/dL}
Glucose175 mg/dL175\text{ mg/dL}7070-110 mg/dL110\text{ mg/dL}

*(Baseline creatinine from one month ago was 0.9 mg/dL0.9\text{ mg/dL})*

Which of the following pharmacologic interventions are most appropriate in the initial management of this patient? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Administer intravenous 0.9%0.9\% sodium chloride; Withhold the patient's home empagliflozin, lisinopril, and naproxen

Cevap

The correct interventions are administering intravenous 0.9%0.9\% sodium chloride and withholding the patient's home empagliflozin, lisinopril, and naproxen.
The correct interventions address the primary life-threatening issue (hypovolemia) while preventing iatrogenic harm. This patient presents with severe hypovolemia secondary to gastrointestinal fluid losses, leading to hypovolemic shock and acute kidney injury (AKI), as evidenced by her hypotension, tachycardia, elevated BUN/creatinine ratio, and physical exam findings. The most urgent pharmacologic intervention is rapid volume resuscitation with an isotonic crystalloid, such as intravenous 0.9%0.9\% sodium chloride, to restore intravascular volume and renal perfusion. Concurrently, it is critical to apply 'sick day rules' and discontinue home medications that can exacerbate AKI or pose severe risks during acute illness. Lisinopril (an ACE inhibitor) and naproxen (an NSAID) impair renal autoregulation (efferent dilation and afferent constriction, respectively) and worsen prerenal AKI. Empagliflozin (an SGLT2 inhibitor) induces osmotic diuresis, exacerbating hypovolemia, and significantly increases the risk of euglycemic diabetic ketoacidosis during periods of physiological stress or starvation.

Adım Adım Çözüm

1
Assess the patient's hemodynamic status and laboratory findings.
The patient exhibits hypotension, tachycardia, delayed capillary refill, and laboratory evidence of acute kidney injury (AKI) with a high BUN/creatinine ratio, indicating severe hypovolemic shock and prerenal AKI.
Establishing the etiology of the AKI dictates immediate management priorities.
2
Select the primary resuscitative intervention.
Identify intravenous 0.9%0.9\% sodium chloride as the urgent treatment of choice.
Restoring intravascular volume is critical to re-establishing adequate renal and systemic perfusion.
3
Review the home medication list to implement 'sick day rules' (medication reconciliation).
Identify that empagliflozin, lisinopril, and naproxen must be discontinued immediately.
These medications exacerbate renal injury and volume depletion during acute illnesses, and holding them prevents further deterioration.

Anahtar Kavram

Management of acute hypovolemic acute kidney injury and implementation of 'sick day rules' for nephrotoxic and volume-depleting medications.
Tahmini Süre:1m 30s
Soru 153Soru →

A 72-year-old man is evaluated prior to discharge from the hospital following an admission for highly symptomatic atrial fibrillation. His past medical history is significant for hypertension, hyperlipidemia, and type 2 diabetes mellitus. During hospitalization, his heart rate remained inadequately controlled despite maximum tolerated doses of metoprolol. The cardiology service initiated oral amiodarone for rhythm control, and the patient successfully converted to normal sinus rhythm. He is transitioning to outpatient care on his newly adjusted medication regimen, which includes amiodarone, metoprolol, apixaban, atorvastatin, and metformin. Which of the following tests are indicated for the routine baseline and ongoing monitoring of his new antiarrhythmic therapy? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Thyroid-stimulating hormone (TSH) level; Hepatic aminotransferase levels

Cevap

The correct monitoring parameters are the Thyroid-stimulating hormone (TSH) level and Hepatic aminotransferase levels.
Amiodarone is a highly efficacious class III antiarrhythmic agent, but its clinical utility is often limited by significant extracardiac toxicities. Because the amiodarone molecule is heavily iodinated and structurally related to thyroid hormone, it frequently causes either hypothyroidism or hyperthyroidism. Consequently, a baseline TSH and periodic reassessments (typically every 6 months) are standard of care. Furthermore, amiodarone is hepatotoxic; baseline and ongoing periodic monitoring of hepatic aminotransferase levels are required to detect subclinical liver injury. Additional routine monitoring for amiodarone includes baseline chest radiography, pulmonary function testing, and regular ophthalmologic exams.

Adım Adım Çözüm

1
Identify the newly prescribed high-risk pharmacotherapy.
The patient has been started on amiodarone for rhythm control of atrial fibrillation.
Different antiarrhythmic agents have distinct side effect profiles that dictate specific long-term monitoring strategies.
2
Determine the common systemic toxicities associated with amiodarone.
Amiodarone is associated with pulmonary toxicity, hepatotoxicity, thyroid dysfunction, and ocular deposits.
Understanding the organ systems affected determines which laboratory and diagnostic tests are required.
3
Select the corresponding baseline and periodic monitoring tests for these toxicities.
Appropriate monitoring includes TSH (for thyroid function) and hepatic aminotransferases (for hepatotoxicity).
These specific laboratory parameters must be checked at baseline and every 6 months to detect asymptomatic end-organ damage.

Anahtar Kavram

Baseline and periodic monitoring for amiodarone therapy includes thyroid function tests (TSH), liver function tests (aminotransferases), pulmonary function testing, and electrocardiography.
Tahmini Süre:1m 15s
Soru 154Soru →

A 52-year-old woman is evaluated in the hospital for worsening erythema, warmth, and swelling of her right lower extremity. She was admitted 3 days ago for severe cellulitis and was started on empiric intravenous vancomycin and piperacillin-tazobactam. Her past medical history is significant for major depressive disorder and type 2 diabetes mellitus. Her home medications, which were continued on admission, include citalopram, metformin, and insulin glargine.

Today, her temperature is 38.4∘C38.4^\circ\text{C} (101.1∘F101.1^\circ\text{F}), blood pressure is 122/78 mmHg122/78\text{ mmHg}, heart rate is 98/min98/\text{min}, and respiratory rate is 16/min16/\text{min}. The erythema on her right leg has expanded proximally despite 72 hours of antimicrobial therapy. Blood cultures drawn on admission remain negative, but a tissue culture obtained from the leading edge of the cellulitis on admission grows *Enterococcus faecium*. Antimicrobial susceptibility testing reveals resistance to ampicillin and vancomycin. Renal function is within normal limits.

Which of the following is the most appropriate pharmacologic intervention for this patient?

Cevabı ve açıklamayı göster

Cevap: Discontinue vancomycin and start daptomycin

Cevap

Discontinue vancomycin and start daptomycin
The correct intervention is to discontinue vancomycin and start daptomycin. This patient has a severe soft tissue infection caused by vancomycin-resistant *Enterococcus faecium* (VRE). Daptomycin, a cyclic lipopeptide, causes rapid depolarization of the bacterial cell membrane and is a first-line, FDA-approved treatment for VRE complicated skin and soft tissue infections. Importantly, it does not interact with the patient's SSRI (citalopram), making it the safest choice.

Adım Adım Çözüm

1
Analyze the culture and susceptibility results.
The patient has a soft tissue infection caused by vancomycin-resistant Enterococcus faecium (VRE).
To identify the pathogen and determine which classes of antibiotics will be ineffective.
2
Identify effective antimicrobial options for VRE.
Standard treatments for VRE include daptomycin, linezolid, and tigecycline.
To narrow down the potential therapeutic choices from the options provided.
3
Evaluate the patient's current medication list for potential drug-drug interactions.
The patient is taking citalopram, a selective serotonin reuptake inhibitor (SSRI).
To ensure the chosen antibiotic does not cause dangerous adverse effects when combined with home medications.
4
Select the safest and most effective antibiotic for this specific patient.
Daptomycin is chosen over linezolid.
Linezolid has reversible MAOI activity and can cause serotonin syndrome if given with an SSRI. Daptomycin is safe and effective for VRE soft tissue infections.

Anahtar Kavram

Management of VRE infections and avoidance of serotonin syndrome with linezolid.
Tahmini Süre:1m 30s
Soru 155Soru →

A 5454-year-old woman is evaluated in the oncology clinic prior to initiating adjuvant therapy for early-stage, HER2-positive breast cancer. Her planned regimen includes weekly paclitaxel concurrently with trastuzumab. She has a history of well-controlled essential hypertension. The physician discusses the potential adverse effects of her targeted therapy, specifically emphasizing the risk of cardiotoxicity, and outlines a comprehensive monitoring protocol. Arrange the following steps regarding the cardiac monitoring and treatment evaluation for this patient in the correct chronological and clinical sequence.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence begins with a baseline LVEF assessment, followed by monitoring every 33 months, withholding the drug if a significant drop (≥16%\geq 16\%) occurs, and then rechecking in 44 weeks to determine if therapy can be safely resumed.
The standard protocol for trastuzumab cardiac monitoring involves first establishing a baseline LVEF, as the drug can cause reversible heart failure. During treatment, monitoring is conducted every 33 months. If a patient experiences an asymptomatic absolute decrease in LVEF of 16%16\% or greater from baseline (or a 10−15%10-15\% decrease that drops the LVEF below institutional normal limits), the medication must be temporarily withheld. Because this cardiotoxicity is often reversible, the next step in treatment evaluation is to repeat the echocardiogram in 44 weeks to check for LVEF recovery, which dictates if the drug can be restarted.

Adım Adım Çözüm

1
Identify the primary adverse effect of the prescribed medication that requires monitoring.
Trastuzumab causes Type II cardiotoxicity, leading to asymptomatic decreases in left ventricular ejection fraction (LVEF) or clinical heart failure.
Recognizing the specific toxicity dictates the required monitoring modality, which in this case is echocardiography or a MUGA scan.
2
Determine the initial workup required before starting the drug.
A baseline echocardiogram must be obtained prior to initiation.
A baseline value is necessary to calculate subsequent drops in LVEF and ensure the patient has adequate cardiac function to withstand the therapy.
3
Determine the appropriate interval for ongoing surveillance.
LVEF should be reassessed every 33 months during therapy.
Frequent, regular monitoring allows for the detection of asymptomatic decline in cardiac function before overt heart failure develops.
4
Identify the threshold for treatment modification and the subsequent follow-up.
Therapy is withheld for a 16%16\% or greater absolute drop in LVEF, followed by a repeat assessment in 44 weeks.
This establishes whether the cardiotoxicity is reversible (as is typical with trastuzumab) and guides the decision to safely resume or permanently discontinue the medication.

Anahtar Kavram

Patients receiving trastuzumab require baseline and ongoing evaluation of left ventricular ejection fraction (LVEF) every 33 months. If LVEF declines significantly, therapy should be held and cardiac function re-evaluated in 44 weeks.
Soru 156Soru →

A 68-year-old male is evaluated in the outpatient clinic for new-onset muscle pain and weakness. He is currently on day 14 of a planned 28-day course of intravenous daptomycin for right-sided infective endocarditis caused by methicillin-resistant *Staphylococcus aureus* (MRSA). His medical history is significant for coronary artery disease and hyperlipidemia, for which he takes aspirin, metoprolol, and rosuvastatin. The patient states that the muscle aches began three days ago, primarily affecting his bilateral thighs and shoulders, making it difficult to stand up from a seated position. His temperature is 37.1°C (98.8°F), blood pressure is 132/84 mmHg, and pulse is 76/min. Physical examination reveals symmetrical muscle tenderness to palpation in the proximal upper and lower extremities. Sensation and deep tendon reflexes are intact. Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Discontinue daptomycin and rosuvastatin, and obtain a serum creatine phosphokinase level

Cevap

The most appropriate next step is discontinuing the offending agents (daptomycin and rosuvastatin) and measuring serum creatine phosphokinase (CPK) levels.
The correct action involves immediately stopping both myotoxic drugs and obtaining a serum creatine phosphokinase (CPK) level. Daptomycin is an active lipopeptide antibiotic known to cause skeletal muscle toxicity. Current guidelines mandate baseline and at least weekly CPK monitoring for all patients on daptomycin. The risk of myopathy and rhabdomyolysis is substantially increased when daptomycin is coadministered with HMG-CoA reductase inhibitors (statins). Given this patient's symptomatic presentation (proximal muscle pain, weakness, and tenderness), the most urgent action is ceasing the offending agents and quantifying muscle breakdown via CPK to guide further management.

Adım Adım Çözüm

1
Evaluate the clinical presentation alongside the patient's active medication list.
Identified symmetric proximal muscle pain and weakness in a patient concurrently taking intravenous daptomycin and a statin.
Both daptomycin and HMG-CoA reductase inhibitors independently carry a significant risk of skeletal muscle toxicity.
2
Determine the necessary therapeutic intervention to prevent further patient harm.
Decision made to immediately halt both daptomycin and rosuvastatin.
Continuing these myotoxic agents in a symptomatic patient can rapidly lead to severe rhabdomyolysis and acute kidney injury.
3
Select the appropriate diagnostic surveillance test to quantify the adverse event.
A serum creatine phosphokinase (CPK) level is ordered.
CPK is the definitive biomarker for skeletal muscle breakdown and is the gold standard for monitoring daptomycin-induced myopathy.

Anahtar Kavram

Patients receiving daptomycin require at least weekly monitoring of serum creatine phosphokinase (CPK). If a patient develops symptomatic myopathy, daptomycin and any other concurrently administered myotoxic drugs (such as statins) must be immediately discontinued and a CPK level obtained.
Soru 157Soru →

A 68-year-old man presents to the clinic with a 4-day history of increased cough, increased sputum volume that has become markedly purulent, and worsening dyspnea. He has a past medical history of severe chronic obstructive pulmonary disease (COPD), hyperlipidemia, and paroxysmal atrial fibrillation. His current daily medications include a tiotropium inhaler, a formoterol inhaler, simvastatin, and sotalol. Vital signs show a temperature of 37.5∘C37.5^\circ\text{C} (99.5∘F99.5^\circ\text{F}), blood pressure of 135/85 mmHg135/85\text{ mmHg}, heart rate of 76/min76/\text{min}, and respiratory rate of 22/min22/\text{min}. Oxygen saturation is 92%92\% on room air. Pulmonary auscultation reveals a prolonged expiratory phase with diffuse bilateral wheezing. Laboratory studies show a leukocyte count of 8,500/μL8,500/\mu L and a serum creatinine of 1.0 mg/dL1.0\text{ mg/dL}. An electrocardiogram obtained in the clinic demonstrates normal sinus rhythm with a corrected QT (QTc) interval of 535 ms535\text{ ms}. The physician plans to prescribe a 5-day course of oral prednisone and optimize the patient's bronchodilator therapy. Which of the following is the most appropriate antimicrobial approach for this patient?

Cevabı ve açıklamayı göster

Cevap: Initiate oral doxycycline

Cevap

The most appropriate approach is to initiate oral doxycycline because it safely covers the expected respiratory pathogens without exacerbating the patient's significantly prolonged QTc interval or interacting with his statin therapy.
The correct approach is to initiate oral doxycycline. This patient presents with an acute exacerbation of COPD meeting all three cardinal Anthonisen criteria (increased dyspnea, increased sputum volume, and increased sputum purulence), which establishes a clear clinical indication for empiric antibiotic therapy. The standard empiric options include macrolides (e.g., azithromycin), respiratory fluoroquinolones (e.g., levofloxacin), doxycycline, or amoxicillin-clavulanate. However, this patient has a baseline QTc interval of 535 ms and is taking sotalol (a Class III antiarrhythmic). A QTc interval greater than 500 ms is a strict absolute contraindication to the use of QT-prolonging medications (including all macrolides and fluoroquinolones) due to the high risk of Torsades de Pointes and sudden cardiac death. Doxycycline provides excellent coverage against the primary respiratory pathogens (Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis) and atypical organisms, without affecting the QT interval or interacting with his statin therapy.

Adım Adım Çözüm

1
Evaluate the indication for antibiotics in this patient's acute COPD exacerbation.
The patient has three cardinal symptoms: increased dyspnea, increased sputum volume, and increased sputum purulence.
According to the Anthonisen criteria, antibiotics are indicated when all three cardinal symptoms are present, or when two are present and one of them is increased purulence. A normal leukocyte count does not negate this strong clinical indication.
2
Identify the common pathogens responsible for COPD exacerbations to determine the required empiric coverage.
Therapy must cover Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae, as well as atypical organisms.
Empiric therapy needs to be broad enough to cover typical bacterial pathogens (many of which produce beta-lactamases) and atypical pathogens.
3
Assess the patient's current medication list and electrocardiogram for absolute contraindications and severe drug-drug interactions.
The patient is taking sotalol and simvastatin, and has a significantly prolonged baseline QTc interval of 535 ms.
Sotalol is a Class III antiarrhythmic that prolongs the QT interval. A QTc > 500 ms poses a high risk for Torsades de Pointes, making any additional QT-prolonging drugs (such as macrolides or fluoroquinolones) absolutely contraindicated. Furthermore, simvastatin is metabolized by CYP3A4, requiring the avoidance of strong CYP3A4 inhibitors.
4
Select the antimicrobial agent that meets all safety and efficacy criteria for this specific patient.
Doxycycline is selected.
Doxycycline provides appropriate antimicrobial coverage, does not prolong the QT interval, and does not inhibit CYP3A4, making it the safest and most effective choice.

Anahtar Kavram

In patients with acute COPD exacerbations meeting clinical criteria for antibiotics, the choice of agent must account for underlying comorbidities and drug interactions, specifically avoiding QT-prolonging macrolides or fluoroquinolones in patients with a prolonged baseline QTc interval.
Tahmini Süre:1m 30s
Soru 158Soru →

An infectious diseases consultation is requested for a 34-year-old male inpatient who has been experiencing progressive dyspnea, dry cough, and subjective fevers over the past three weeks. His past medical history is notable for an HIV diagnosis five years prior; however, he abandoned antiretroviral therapy two years ago. Vital signs reveal a temperature of 38.4∘C38.4^\circ\text{C} (101.1∘F101.1^\circ\text{F}), blood pressure of 112/70 mmHg, heart rate of 110/min, and respiratory rate of 24/min. Pulse oximetry demonstrates an oxygen saturation of 88%88\% while breathing ambient air, and a subsequent arterial blood gas analysis confirms a PaO2\text{PaO}_2 of 65 mmHg. Chest radiography displays bilateral, fine interstitial infiltrates. Microscopic examination of induced sputum using direct fluorescent antibody testing definitively identifies *Pneumocystis jirovecii*.

Which of the following pharmacologic interventions should be ordered immediately for this patient? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Intravenous trimethoprim-sulfamethoxazole; Oral prednisone

Cevap

The correct interventions to order immediately are intravenous trimethoprim-sulfamethoxazole and oral prednisone.
The patient has severe Pneumocystis jirovecii pneumonia (PCP), as indicated by the positive sputum direct fluorescent antibody testing and significant hypoxemia. Intravenous trimethoprim-sulfamethoxazole is the standard first-line antimicrobial therapy for moderate-to-severe PCP. Furthermore, because the patient has a PaO2\text{PaO}_2 of less than 70 mmHg (specifically 65 mmHg in this scenario), adjunctive corticosteroids such as oral prednisone or intravenous methylprednisolone are strictly required. Corticosteroids critically reduce the severe inflammatory response triggered in the lungs by the rapid lysis of fungal organisms, significantly decreasing the risk of subsequent respiratory failure and mortality.

Adım Adım Çözüm

1
Assess the severity of the opportunistic infection.
The patient's PaO2\text{PaO}_2 is 65 mmHg on room air.
A PaO2<70\text{PaO}_2 < 70 mmHg or an A-a\text{A-a} gradient ≥35\geq 35 mmHg defines moderate-to-severe PCP, which alters the standard treatment protocol by requiring adjunctive therapy.
2
Select the primary antimicrobial agent.
Intravenous trimethoprim-sulfamethoxazole is chosen.
It remains the standard, most effective first-line targeted therapy for active Pneumocystis jirovecii pneumonia.
3
Identify the critical need for adjunctive pharmacotherapy based on severity parameters.
Oral prednisone (or intravenous methylprednisolone) is added to the regimen.
Adjuvant corticosteroids prevent rapid clinical deterioration caused by the intense inflammatory response triggered by dying PCP organisms in already hypoxic patients.

Anahtar Kavram

Patients with moderate-to-severe Pneumocystis jirovecii pneumonia, defined by a PaO2 < 70 mmHg or an A-a gradient >= 35 mmHg, must receive both targeted antimicrobial therapy (trimethoprim-sulfamethoxazole) and adjunctive corticosteroids.
Tahmini Süre:1m 30s
Soru 159Soru →

A retrospective cohort study investigates the association between a new oral hypoglycemic agent and the risk of severe hypoglycemia. The initial unadjusted analysis shows a relative risk (RR) of 2.8 (95% CI: 1.9 - 3.7). The researchers note that patients prescribed the new agent generally have a longer duration of diabetes. They decide to stratify the patients into two groups: those with diabetes for less than 10 years and those with diabetes for 10 years or more. Following stratification, the RR for severe hypoglycemia associated with the new agent is 1.0 (95% CI: 0.8 - 1.2) in both stratified groups. Which of the following best describes the role of diabetes duration in this study?

Cevabı ve açıklamayı göster

Cevap: Confounding variable

Cevap

Confounding variable
The correct answer is Confounding variable. Confounding occurs when a third variable is associated with both the exposure and the outcome, creating a false association. The classic method to identify confounding is stratification. If stratifying by the suspected third variable causes the original association to disappear (the relative risks in the strata become approximately 1.0), then that third variable is a confounder.

Adım Adım Çözüm

1
Analyze the crude (unadjusted) relative risk.
The unadjusted RR is 2.8, suggesting a significant positive association between the new drug and severe hypoglycemia.
Establishing the baseline association is necessary before evaluating the impact of stratification.
2
Evaluate the results after stratifying by diabetes duration.
In both the <10 years and ≥10 years strata, the RR becomes 1.0, meaning there is no association within the specific subgroups.
Stratification helps distinguish whether a third variable is driving the observed crude association or modifying it.
3
Interpret the change in relative risk.
Because the association completely disappears upon stratification, the original crude association was entirely driven by the unequal distribution of the third variable (diabetes duration) between the exposure groups.
This pattern (crude association disappears upon stratification) is the defining epidemiological signature of a confounding variable.

Anahtar Kavram

Confounding versus Effect Modification
Tahmini Süre:1m 0s
Soru 160Soru →

A 63-year-old female presents to the clinic for a routine annual wellness examination. She feels well and has no acute complaints. Her medical history is significant for type 2 diabetes mellitus and primary hypertension. Her current medications include metformin and lisinopril. Vital signs are within normal limits, and her body mass index is 27 kg/m². She has never smoked and drinks one glass of wine on weekends.

Review of her preventive care history reveals the following:
- Screening mammography: Performed 11 months ago, BI-RADS 1 (negative).
- Cervical cancer screening: Pap smear with HPV co-testing performed at age 60, negative for intraepithelial lesions and high-risk HPV.
- Colorectal cancer screening: Colonoscopy performed at age 53, revealing no polyps or abnormalities.
- Vaccinations: Received 2 doses of the recombinant zoster vaccine at age 50. Received the 20-valent pneumococcal conjugate vaccine (PCV20) at age 61. Received a Tdap booster 6 years ago. Received an annual influenza vaccine last month.

The patient asks if she is due for any other screening tests or preventive medications today. Which of the following is the most appropriate next step in this patient's preventive care?

Cevabı ve açıklamayı göster

Cevap: Screening colonoscopy

Cevap

The most appropriate next step is to perform a screening colonoscopy, as it has been 10 years since her last normal examination.
The most appropriate next step in preventive care for this patient is a screening colonoscopy. According to the United States Preventive Services Task Force (USPSTF), average-risk adults should undergo colorectal cancer screening between ages 45 and 75. For individuals utilizing colonoscopy as their screening modality, the recommended interval is every 10 years following a normal exam. Because this patient's last colonoscopy was performed 10 years ago at age 53, she is currently due for repeat screening.

Adım Adım Çözüm

1
Evaluate the patient's colorectal cancer screening status.
The patient is 63 years old and her last colonoscopy was 10 years ago at age 53.
The United States Preventive Services Task Force (USPSTF) recommends colorectal cancer screening for average-risk adults aged 45 to 75. A normal colonoscopy establishes a 10-year interval for the next screening.
2
Assess the interval for breast and cervical cancer screening.
The patient had a mammogram 11 months ago (due in 13 months) and Pap/HPV co-testing 3 years ago (due in 2 years).
USPSTF guidelines recommend biennial (every 2 years) mammography for women aged 40-74, and cervical cancer co-testing every 5 years for women aged 30-65.
3
Determine the indication for an osteoporosis screening (DEXA) scan.
The patient is 63, lacks major osteoporotic risk factors, and has a normal BMI.
Routine DEXA screening begins at age 65 for average-risk women. Women under 65 are only screened if their 10-year fracture risk meets or exceeds that of a 65-year-old white woman.
4
Review the guidelines for primary prevention of cardiovascular disease with aspirin.
The patient is over 60 without a history of atherosclerotic cardiovascular disease.
Current guidelines recommend against starting low-dose aspirin for primary prevention in adults 60 and older due to the net harm from bleeding risks.

Anahtar Kavram

Ambulatory adult preventive care guidelines require tracking and applying distinct screening intervals for colorectal, breast, and cervical cancers, as well as age-specific contraindications for primary prevention medications.
ÖncekiSayfa 8 / 237Sonraki
Tüm alıştırma soruları — USMLE Step 3 | Examkin